LCLinda J. Cobiac

Linda J. Cobiac

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Linda J. Cobiac has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Theo Vos

    School of Population Health, The University of Queensland, Herston, Queensland, 4006 Australia

    8 shared publications
  • Jacob Lennert Veerman

    Public Health and Economics Modelling Group, School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia

    5 shared publications
  • Anne Magnus

    Deakin Health Economics, Centre for Population Health Research, Faculty of Health, Deakin University, Geelong, Victoria, Australia

    2 shared publications
  • Angela Wallace

    School of Population Health, The University of Queensland, Queensland, Australia

    1 shared publication
  • Anne Magnus

    Deakin Health Economics, Strategic Research Centre – Population Health, Deakin University, Burwood, Victoria, Australia

    1 shared publication
  • Christopher Doran

    National Drug and Alcohol Research Centre, University of New South Wales, New South Wales, Australia

    1 shared publication

Latest Publications

  • Modelling the implications of regular increases in tobacco taxation in the tobacco endgame

    by Linda J Cobiac, Tak Ikeda, Nhung Nghiem, Tony Blakely, Nick Wilson

    Objective We examine the potential role for taxation in the tobacco endgame in New Zealand, where the goal is to become ‘smokefree’ (less than 5% smoking prevalence) by 2025. Design Modelling study using a dynamic population model. Setting and participants New Zealand, Māori and non-Māori men and women. Interventions Annual increases in tobacco excise tax of 5%, 10%, 15% and 20% (with 10% reflecting the annual increase recently legislated by the New Zealand Government to 2016). Results With a continued commitment to annual 10% increases in tobacco excise tax, in addition to on-going Quitline and cessation support, New Zealand's smoking prevalence is projected to fall from 15.1% in 2013 to 8.7% (95% uncertainty interval 8.6% to 8.9%) by 2025. This is compared to 9.9% without any further tax rises. With annual tax increases of 20%, the prevalence is projected to fall to 7.6% (7.5% to 7.7%) by 2025. The potential reductions in smoking prevalence are substantial for both Māori and non-Māori populations, although annual tax increases as high as 20% will still only see Māori smoking prevalence in 2025 approaching the non-Māori smoking levels for 2013. Scenario analyses did not suggest that growth of the illicit tobacco market would substantively undermine the impact of tobacco tax rises. Nevertheless, unknown factors such as the gradual denormalisation of smoking and changes to the ‘nicotine market’ may influence sensitivity to changes in tobacco prices in the future. Conclusions Regular increases in tobacco taxation could play an important role in helping to achieve tobacco endgames. However, this modelling in New Zealand suggests that a wider range of tobacco endgame strategies will be needed to achieve a smoke-free goal of less than 5% prevalence for all social groups—a conclusion that could also apply in other countries.


  • Economic evaluation of potential fiscal strategies to improve Indigenous nutrition and health in remote communities of Australia

    by Anne Magnus, Marj L. Moodie, Megan Ferguson, Linda J. Cobiac, Selma C. Liberato, Julie Brimblecombe


  • The Role of Cost-Effectiveness Analysis in Developing Nutrition Policy

    by Linda J. Cobiac, Lennert Veerman, Theo Vos

    Concern about the overconsumption of unhealthy foods is growing worldwide. With high global rates of noncommunicable diseases related to poor nutrition and projections of more rapid increases of rates in low- and middle-income countries, it is vital to identify effective but low-cost interventions. Cost-effectiveness studies show that individually targeted dietary interventions can be effective and cost-effective, but a growing number of modeling studies suggest that population-wide approaches may bring larger and more sustained benefits for population health at a lower cost to society. Mandatory regulation of salt in processed foods, in particular, is highly recommended. Future research should focus on lacunae in the current evidence base: effectiveness of interventions addressing the marketing, availability, and price of healthy and unhealthy foods; modeling health impacts of complex dietary changes and multi-intervention strategies; and modeling health implications in diverse subpopulations to identify interventions that will most efficiently and effectively reduce health inequalities.


  • Open Access

    Which Interventions Offer Best Value for Money in Primary Prevention of Cardiovascular Disease?

    by Linda J. Cobiac, Anne Magnus, Stephen Lim, Jan J. Barendregt, Rob Carter, Theo Vos

    Despite many decades of declining mortality rates in the Western world, cardiovascular disease remains the leading cause of death worldwide. In this research we evaluate the optimal mix of lifestyle, pharmaceutical and population-wide interventions for primary prevention of cardiovascular disease. In a discrete time Markov model we simulate the ischaemic heart disease and stroke outcomes and cost impacts of intervention over the lifetime of all Australian men and women, aged 35 to 84 years, who have never experienced a heart disease or stroke event. Best value for money is achieved by mandating moderate limits on salt in the manufacture of bread, margarine and cereal. A combination of diuretic, calcium channel blocker, ACE inhibitor and low-cost statin, for everyone with at least 5% five-year risk of cardiovascular disease, is also cost-effective, but lifestyle interventions aiming to change risky dietary and exercise behaviours are extremely poor value for money and have little population health benefit. There is huge potential for improving efficiency in cardiovascular disease prevention in Australia. A tougher approach from Government to mandating limits on salt in processed foods and reducing excessive statin prices, and a shift away from lifestyle counselling to more efficient absolute risk-based prescription of preventive drugs, could cut health care costs while improving population health.


  • Open Access

    Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study

    by Linda J Cobiac, Anne Magnus, Jan J Barendregt, Rob Carter, Theo Vos

    Cardiovascular disease is the leading cause of death worldwide. Like many countries, Australia is currently changing its guidelines for cardiovascular disease prevention from drug treatment for everyone with ‘high blood pressure’ or ‘high cholesterol’, to prevention based on a patient’s absolute risk. In this research, we model cost-effectiveness of cardiovascular disease prevention with blood pressure and lipid drugs in Australia under three different scenarios: (1) the true current practice in Australia; (2) prevention as intended under the current guidelines; and (3) prevention according to proposed absolute risk levels. We consider the implications of changing to absolute risk-based cardiovascular disease prevention, for the health of the Australian people and for Government health sector expenditure over the long term.


  • Cost‐effectiveness of extending the coverage of water supply fluoridation for the prevention of dental caries inAustralia

    by Linda J. Cobiac, Theo Vos

    Objective: Fluoride was first added to theAustralian water supply in 1953, and by 2003, 69% ofAustralia's population was receiving the minimum recommended dose. Extending coverage of fluoridation to all remaining communities of at least 1000 people is a key strategy ofAustralia'sNationalOralHealthPlan 2004–2013. We evaluate the cost‐effectiveness of this strategy from anAustralian health sector perspective.Methods: Health gains from the prevention of caries in theAustralian population are modelled over the average 15‐year lifespan of a treatment plant. Taking capital and on‐going operational costs of fluoridation into account, as well as costs of caries treatment, we determine the dollars per disability‐adjusted life years (DALY) averted from extending coverage of fluoridation to all large (≥1000 people) and small (<1000 people) communities inAustralia.Results: Extending coverage of fluoridation to all communities of at least 1000 people will lead to improved population health (3700DALYs, 95% uncertainty interval: 2200–5700DALYs), with a dominant cost‐effectiveness ratio and 100% probability of cost‐savings. Extending coverage to smaller communities leads to 60% more health gains, but is not cost‐effective, with a median cost‐effectiveness ratio ofA$92 000/DALYand only 10% probability of being under a cost‐effectiveness threshold ofA$50 000/DALY.Conclusions: Extension of fluoridation coverage under theNationalOralHealthPlan is highly recommended, but given the substantial dental health disparities and inequalities in access to dental care that currently exist for more regional and remote communities, there may be good justification for extending coverage to include allAustralians, regardless of where they live, despite less favourable cost‐effectiveness.


  • Open Access

    Cost-Effectiveness of Interventions to Promote Fruit and Vegetable Consumption

    by Linda J. Cobiac, Theo Vos, J. Lennert Veerman

    Fruits and vegetables are an essential part of the human diet, but many people do not consume the recommended serves to prevent cardiovascular disease and cancer. In this research, we evaluate the cost-effectiveness of interventions to promote fruit and vegetable consumption to determine which interventions are good value for money, and by how much current strategies can reduce the population disease burden. In a review of published literature, we identified 23 interventions for promoting fruit and vegetable intake in the healthy adult population that have sufficient evidence for cost-effectiveness analysis. For each intervention, we model the health impacts in disability-adjusted life years (DALYs), the costs of intervention and the potential cost-savings from averting disease treatment, to determine cost-effectiveness of each intervention over the lifetime of the population, from an Australian health sector perspective. Interventions that rely on dietary counselling, telephone contact, worksite promotion or other methods to encourage change in dietary behaviour are not highly effective or cost-effective. Only five out of 23 interventions are less than an A$50,000 per disability-adjusted life year cost-effectiveness threshold, and even the most effective intervention can avert only 5% of the disease burden attributed to insufficient fruit and vegetable intake. We recommend more investment in evaluating interventions that address the whole population, such as changing policies influencing price or availability of fruits and vegetables, to see if these approaches can provide more effective and cost-effective incentives for improving fruit and vegetable intake.


  • Cost-effectiveness of interventions to reduce dietary salt intake

    by Linda J Cobiac, Theo Vos, J Lennert Veerman

    Objective To evaluate population health benefits and cost-effectiveness of interventions for reducing salt in the diet. Design Proportional multistate life-table modelling of cardiovascular disease and health sector cost outcomes over the lifetime of the Australian population in 2003. Interventions The current Australian programme of incentives to the food industry for moderate reduction of salt in processed foods; a government mandate of moderate salt limits in processed foods; dietary advice for everyone at increased risk of cardiovascular disease and dietary advice for those at high risk. Main Outcome Measures Costs measured in Australian dollars for the year 2003. Health outcomes measured in disability-adjusted life years (DALY) averted over the lifetime. Results Mandatory and voluntary reductions in the salt content of processed food are cost-saving interventions under all modelled scenarios of discounting, costing and cardiovascular disease risk reversal (dominant cost-effectiveness ratios). Dietary advice targeting individuals is not cost-effective under any of the modelled scenarios, even if directed at those with highest blood pressure risk only (best case median cost-effectiveness A$100 000/DALY; 95% uncertainty interval A$64 000/DALY to A$180 000/DALY). Although the current programme that relies on voluntary action by the food industry is cost-effective, the population health benefits could be 20 times greater with government legislation on moderate salt limits in processed foods. Conclusions Programmes to encourage the food industry to reduce salt in processed foods are highly recommended for improving population health and reducing health sector spending in the long term, but regulatory action from government may be needed to achieve the potential of significant improvements in population health.